KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
1.30
+0.01 (+0.78%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close1.29
Open1.31
Bid1.29 x 0
Ask1.30 x 0
Day's Range1.23 - 1.31
52 Week Range1.02 - 1.43
Volume516,720
Avg. Volume522,115
Market Cap60.908M
Beta0.20
PE Ratio (TTM)N/A
EPS (TTM)-0.21
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group2 days ago

    Khiron VP, Compliance Matt Murphy Appears on CBS Network's 60 Minutes to Discuss Law Enforcement and the Global Opioid Crisis

    TORONTO , June 19, 2018 /CNW/ - Khiron Life Sciences Corp. (KHRN.V), a Canadian integrated medical cannabis company with its core operations in Colombia , announced today that its newly appointed Vice President of Compliance, Matt Murphy , appeared on CBS Network's June 17, 2018 airing of 60 Minutes to discuss important aspects of the U.S. opioid crisis. Murphy and other senior U.S. Drug Enforcement Administration (DEA) agents revealed in the program detailed investigative accounts that expose a failure by the U.S. pharmaceutical industry to regulate itself and stem the massive flow of opioid-based painkillers into the consumer marketplace.

  • CNW Group7 days ago

    Khiron Forms Exclusive Strategic Alliance with ILANS, Expanding Distribution Network to Over 500,000 Patients

    TORONTO , June 14, 2018 /CNW/ - Khiron life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), a Canadian integrated medical cannabis company with its core operations in Colombia , announced today that the Company has formed an exclusive strategic alliance with Latin American Institute of Neurology and the Nervous System ("ILANS"), one of the most respected, fastest growing, and largest health service provider networks in Colombia and Latin America . ILANS represents an estimated 100,000 patients, with the majority of these patients being located in Colombia .

  • CNW Group8 days ago

    Khiron Achieves Key Milestone in Mission to Become First Medical Cannabis Company to Bring Products to Market in Colombia

    Colombian Agricultural Institute ("ICA") authorization is a significant requirement to cultivate and distribute medical cannabis in Colombia . TORONTO , June 13, 2018 /CNW/ - Khiron life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), a Canadian integrated medical cannabis company with its core operations in Colombia , announced today that the Company has been registered by the Colombian Agricultural Institute ("ICA") as an agronomical unit.

  • Khiron Life Sciences Corp. Opens the Market
    CNW Group10 days ago

    Khiron Life Sciences Corp. Opens the Market

    Khiron Life Sciences Corp. Opens the Market

  • CNW Group10 days ago

    Khiron Secures Medical Cannabis Endorsements from Two of the Largest Medical Associations in Colombia

    TORONTO , June 11, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), a Canadian integrated medical cannabis company with its core operations in Colombia , announced today that it has received endorsements and signed co-operation agreements with two of the largest and most recognized medical associations in the country: The Colombian Association of Internal Medicine (ACMI) and the Colombian Association of Neurology (ACN). As a result, Khiron becomes the first medical cannabis company in Colombia to be endorsed by two medical associations and to be in a position to directly introduce its brand to a national audience of almost 3,000 doctors.

  • CNW Group12 days ago

    Khiron to Open TSX Venture Exchange and Host Media Interviews on June 11, 2018

    TORONTO , June 8, 2018 /CNW/ - Khiron life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), a Canadian integrated medical cannabis company with its core operations in Colombia , will open the market of the TSX Venture Exchange on Monday, June 11, 2018 at 9:30 a.m. EDT . Khiron, as the first cannabis company with active operations in Colombia to list on any exchange globally, will be meeting with members of media after the market opens. Khiron has positioned itself as the leading medical cannabis company in Latin America .

  • PR Newswire21 days ago

    KCSA Strategic Communications Announces June 7th Cannabis Virtual Investor Conference

    NEW YORK , May 31, 2018 /PRNewswire/ --  KCSA Strategic Communications , an integrated public relations, media relations, social media, and investor relations agency, today announced its Virtual Investor ...

  • CNW Group21 days ago

    Khiron Appoints Former DEA Chief of Pharmaceutical Investigations Matt Murphy as Vice President, Compliance

    TORONTO , May 31, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), a Canadian integrated medical cannabis company with its core operations in Colombia , announced today that it has appointed former U.S. Drug Enforcement Administration ("DEA"), Chief of Pharmaceutical Investigations, Matt Murphy , as the Company's Vice President, Compliance.

  • CNW Group22 days ago

    Khiron Receives INVIMA Approval to Commercialize CBD Products for Colombian Domestic Sale and Export

    TORONTO , May 30, 2018 /CNW/ - Khiron life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), a Canadian integrated medical cannabis company with its core operations in Colombia , announced today that The Colombia National Food and Drug Surveillance Institute ("INVIMA"), a level four World Health Organization ("WHO") agency, has granted Khiron authorization for the production, sale and export of four cannabidiol ("CBD") based products.

  • CNW Group23 days ago

    Khiron Strategically Positioned to Enter Mexican Medical Cannabis Market

    TORONTO , May 29, 2018 /CNW/ - Khiron life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), a Canadian integrated medical cannabis company with its core operations in Colombia , announced today the Company is strategically positioned to enter the medical cannabis market in Mexico by acting as a key sponsor of the CannaMexico World Summit. The conference will be hosted by former Mexican President, Vicente Fox Quesada , a leading advocate for medical cannabis as an alternative treatment method for a wide range of medical conditions.